Abstract 4141
Background
To compare left-upper, right and left inferior split-lobe procedures with the same lobectomies for surgical treatment of peripheral non-small cell lung cancer of stage IA-IB, originating from the large pulmonary lobes.
Methods
We analyzed the results of the treatment of 116 patients, who underwent surgical procedures for clinical stage IA-IB non-small cell lung cancer. Patients were divided into two groups, based on the type of procedure performed. Lobectomies were performed in 78 (67,2%) patients, split-lobe resections of the large pulmonary lobes in 38 (32,8%): upper left trisegmentectomy (S1,2,3) in 14 patients, resection of the lingula (S4,5) in 7, anatomical segmentectomy S6 in 15, resection of basal segments in 2 patients. Radical mediastinal lymph node dissection was performed in all cases. The primary end-points of the analysis were relapse-free survival (RFS), overall survival (OS) and rate of recurrence (RR).
Results
There were no significant differences in morbidity between lobectomy and split-lobe resection groups (7,7% vs. 5,3%; p=NS). RR was registered in 9 patients in the lobectomy group vs 7 patients from split-lobe group (11,5% vs. 18,4%; p=NS). Regional recurrence in hilar lymph nodes was confirmed only in one patient from split-lobe group 28 months after right anatomical segmentectomy S6. Survival analysis did not show significant differences between lobectomy and split-lobe groups. Overall 5-year survival was 82,0% (95% confidence interval, 70,3-93,7%) in lobectomy group versus 74,8% (95% confidence interval, 57,5-97,1%) in split-lobe group (p = 0,369). Relapse-free 5-year survival was 85,2% (95% confidence interval, 76,8-94,6%) in lobectomy group versus 76,2% (95% confidence interval, 59,6-92,8%) in split-lobe group (p = 0,353). Cox regression analysis with multiple factors demonstrated statistical significance for overall (p = 0,03) and relapse-free (p = 0,025) survival only for pT1-T2 tumour descriptors.
Conclusions
Split-lobe procedures and lobectomy have equivalent in-hospital morbidity and long-term results for patients with clinical stage IA-IB peripheral non-small cell LC. In the future split-lobe resection can be recommended as a standard procedure for early stage peripheral non-small cell LC.
Clinical trial identification
Legal entity responsible for the study
City Clinical Hospital no. 40.
Funding
Has not received any funding.
Editorial Acknowledgement
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
5877 - TCR beta chain convergence defines the tumor infiltrating T cell repertoire of melanoma and non-small cell lung carcinoma.
Presenter: Timothy Looney
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
3212 - PI3K inhibition and modulation of immune and tumor microenvironment markers by copanlisib in patients with non-Hodgkin's lymphoma or advanced solid tumors
Presenter: Ahmad Awada
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
3574 - Pan-squamous genomic profiling stratified by anatomic tumor site and viral association
Presenter: Meagan Montesion
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
4113 - Toward the Standardization of Bioinformatics Methods for the Accurate Assessment of Tumor Mutational Burden (TMB)
Presenter: Han Chang
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
4468 - Prediction of primary resistance to anti-PD1 therapy (APD1) in 2nd line NSCLC
Presenter: Egbert Smit
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
4570 - Immunomodulatory germline variation impacts the development of multiple primary melanoma (MPM).
Presenter: Robert Ferguson
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
1169 - Leukocyte telomere length and recurrence risk after EGFR-TKIs therapy in patients with advanced lung adenocarcinoma
Presenter: Ming Yang
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
1707 - Gene embedding: a novel machine learning approach to identify gene candidates related to immunotherapy responsiveness
Presenter: Chi Tung Choy
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
2123 - Common and rare DPYD variants are predictive for 5FU/capecitabine (5FU) toxicity: The MRC COIN and COIN-B trials
Presenter: Ayman Madi
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
5671 - The landscape of NTRK fusions in Chinese solid tumor patients
Presenter: Qi Ling
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract